GoHealth
GOCO
GOCO was delisted on the 15th of June, 2026.
67 hedge funds and large institutions have $14M invested in GoHealth in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 4 closing their positions.
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
54% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 13
20% more funds holding
Funds holding: 56 → 67 (+11)
1.56% more ownership
Funds ownership: 56.17% → 57.73% (+1.6%)
28% less capital invested
Capital invested by funds: $19.4M → $14M (-$5.41M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$164K |
| 2 |
CF
CDC Financial
Chicago,
Illinois
|
+$92K |
| 3 |
BOCH
Blue Owl Capital Holdings
New York
|
+$77.9K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$52.8K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$49.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$23.4K |
| 2 |
AHL
Abel Hall LLC
Baton Rouge,
Louisiana
|
-$22.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$19K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.2K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$13.4K |
GOCO Hedge Fund Activity: Q1 2026 in Review
67 of the 8,202 institutional investors tracked by Wall St. Rank reported a position in GoHealth (GOCO) for Q1 2026, worth a combined $14M — down 28% from $19.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new GOCO positions and 4 closed out — a net gain of 12 holders — while 20 added to existing stakes and 13 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $164K. The largest seller was Barclays, cutting an estimated $23.4K.
- 67 institutional investors held GoHealth (GOCO) as of Q1 2026, up from 56 in Q4 2025.
- Funds reported $14M of GoHealth stock for Q1 2026, down 28% quarter-over-quarter.
- 16 funds opened new GoHealth positions in Q1 2026 and 4 closed out, a net change of +12 holders.
- The largest GoHealth buyer in Q1 2026 was Geode Capital Management, an estimated $164K added.
- The largest GoHealth seller in Q1 2026 was Barclays, an estimated $23.4K sold.
Based on aggregated 13F filings for Q1 2026.